The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

CIRCA CENTRE, 2929 ARCH STREET, PHILADELPHIA, PA 19104-2808, USA
Tel:
Work +1 215 994 4000
Fax:
Fax +1 215 994 2222
Email:
Web:
www.dechert.com

Michael L Kichline

Tel:
Work +1 215 994 2439
Email:
Dechert LLP

Work Department

Litigation

Career

Michael L. Kichline is a co-leader of the firm’s global securities and corporate governance litigation practice. His more than two decades of experience span a diverse range of complex, high-stakes matters, including securities class actions, derivative suits, M&A disputes, ERISA, consumer class actions, business torts, contract disputes, legal malpractice defense and appellate matters.

 

 

Member

Trustee, Philadelphia Bar Foundation; Litigation Section, American Bar Association; Member, National Association of Corporate Directors; Member, Temple American Inn of Court; Member, Supreme Court Historical Society; Member, Eastern District of Pennsylvania Historical Society; Member, Pennsylvanians for Modern Courts, Member, Pennsylvania Business Council

Education

Temple University, B.A., 1988, magna cum laude; Temple University Beasley School of Law, J.D., 1991, magna cum laude, member of the Moot Court Honor Society


United States: Dispute resolution

Securities litigation: defense

Within: Securities litigation: defense

Dechert LLPprovides excellent levels of service from experts in the law and dogged fighters for their clients’ interests’. The firm has ‘star power among its senior talent’, which includes firm chairman Andrew Levander, who last year argued an appeal for Rockstar Games. David Kistenbroker, who practices in both New York and Chicago, is global head of the securities litigation practice. With Joni Jacobsen in Chicago, he represented Asanko Gold in a 10b-5 class action in which plaintiffs alleged the company made false or misleading statements about mineral resource estimates. The same team secured the dismissal of a 10b-5 case for Anavex Life Sciences and former executives that centered on claims that they misled investors about the efficacy of an experimental Alzheimer’s drug to artificially inflate the price of its stock. Global litigation head Matthew Larrabee in New York and key partner Michael Kichline in Philadelphia are also recommended.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to